Trial NCT01548573

View at ClinicalTrials.gov 
Org. Study IDs: 201202818
Secondary IDs: 7R01CA115399

Last trial update was posted on 2017-06-14

MeSH Interventions

Bortezomib Cyclophosphamide Dexamethasone Doxorubicin Etoposide Etoposide phosphate Liposomal doxorubicin Melphalan Thalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Met study stopping rules

Limitations And Caveats

Enrollment halted prematurely. Study met stopping rules. Outcomes will not be tracked and published

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID